Biosimilars in psoriasis: what should your positioning be?

Expert Opinion on Biological Therapy
Ricardo Ruiz-Villaverde, Manuel Galán-Gutierrez

Abstract

The introduction of biosimilars into our therapeutic arsenal has revolutionized the accessibility of biological treatments to patients with psoriasis, mainly from an economic standpoint. At this point, it is interesting to assess what their current positioning is. A bibliographic review has been carried out that includes the technical sheets of the different drugs, criteria for the use of biosimilars, the current situation of the main prescribing countries, and data on actual clinical practice in the period 2015-2020 using the Pubmed® and Embase databases. ®.Accessibility varies from country to country, regardless of the standards set by the Food and Drug Administration (FDA) or European Medicines Agency (EMA), owing to the need for biosimilars to be submitted for approval to local regulatory agencies. The switching/interchangeability/substitution criteria are not homogeneous, with variable outcomes ranging from clinical trials (for example, Norway) to mere non-binding recommendations. The use of biosimilars is appropriate for a high percentage of patients. Its position as first-line drugs compared to traditional systemic drugs and the new anti-IL molecules must be reviewed since clinical choice cannot be based on economic aspe...Continue Reading

References

Aug 21, 2007·Journal of the American Academy of Dermatology·Elizabeth J HornMark Lebwohl
Apr 5, 2014·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Marc Alexander Radtke, Matthias Augustin
Nov 6, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·L Puig
May 20, 2015·Actas dermo-sifiliográficas·L PuigUNKNOWN en nombre del Grupo de Psoriasis de Academia Española de Dermatología y Venereología
Jun 8, 2015·Actas dermo-sifiliográficas·L PuigUNKNOWN en nombre del Grupo de Psoriasis de Academia Española de Dermatología y Venereología
Jan 7, 2017·Acta Médica Portuguesa·Tiago TorresPaulo Filipe
Dec 31, 2017·Annals of the Rheumatic Diseases·Fabrizio Cantini, Maurizio Benucci
Jan 10, 2018·The British Journal of Dermatology·B Kirby
Oct 18, 2018·Acta Médica Portuguesa·Alexandra AzevedoTiago Torres
Jun 27, 2019·Expert Opinion on Biological Therapy·Lluís Puig, Anna López-Ferrer
Mar 20, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·P GisondiG Girolomoni

❮ Previous
Next ❯

Citations

Aug 11, 2021·Pharmaceutics·Jen-Chih TsengTsung-Hsien Chuang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

ESMO Open
Miguel Martin
Zeitschrift für Rheumatologie
G-R Burmester, U Müller-Ladner
JAMA Oncology
Sandeep Parsad, Chadi Nabhan
Lupus
Christopher J Edwards, Salvatore Bellinvia
Journal of Drugs in Dermatology : JDD
Jerry Bagel
© 2021 Meta ULC. All rights reserved